EUROLAB
usp-2048-dissolution-for-oral-thin-films
Dissolution and Disintegration Testing EMA Guideline on the Investigation of Bioequivalence—Dissolution CriteriaFDA Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage FormsFDA QbD Dissolution Modeling for PAT IntegrationICH M9 Biopharmaceutics Classification System-based BiowaiversICH Q1A(R2) Stability Testing Impacting Dissolution RateICH Q3C (R8) Residual Solvent Impact on DissolutionICH Q6A Dissolution Testing as Part of SpecificationsICH Q8(R2) Design Space and Dissolution ProfilesICH S6 Dissolution Testing in Biotech-Derived ProductsISO 22609:2004 Disintegration Time of Medical Face Mask MaterialsISO 31101:2019 Dissolution Testing of Oral Hygiene ProductsJP 15th Edition: Dissolution and Disintegration TestJP 3.09 Disintegration Test for Capsules and TabletsJP General Chapter 6.10 Dissolution Test for SuppositoriesPh. Eur. 2.9.1 Disintegration Test for Solid Dosage FormsPh. Eur. 2.9.29 Disintegration of Tablets for Veterinary UsePh. Eur. 2.9.3 Dissolution Testing of Oral Dosage FormsPh. Eur. 2.9.39 Dissolution of Patches and ImplantsPh. Eur. 2.9.4 Dissolution of Modified Release Dosage FormsPh. Eur. 2.9.40 Dissolution Testing for Oral SuspensionsPh. Eur. 2.9.43 In Vitro Dissolution Testing of Inhaled ProductsPh. Int. 2.9.5 Disintegration Testing of SuppositoriesUSP <1002> Dissolution Testing for Powder-Filled CapsulesUSP <1004> Disintegration Testing of Vaginal TabletsUSP <1087> Assessment of Drug Release from Extended Release TabletsUSP <1088> In Vitro Dissolution Profile Comparison for Generic DrugsUSP <1090> Assessment of Drug Release from Liposomal Dosage FormsUSP <1091> Assessment of Drug Release from MicrospheresUSP <1092> Dissolution Procedure Development and ValidationUSP <1094> Capsules—Dissolution and DisintegrationUSP <1097> Dissolution Testing for Transmucosal Drug Delivery SystemsUSP <2040> Dissolution Testing for Dietary SupplementsUSP <2041> Dissolution Testing of Oral Disintegrating TabletsUSP <2042> Disintegration and Dissolution of Buccal TabletsUSP <2043> Disintegration Testing of Chewable TabletsUSP <2044> Disintegration Testing for Orally Disintegrating TabletsUSP <2045> Dissolution of Transdermal PatchesUSP <2046> Disintegration of Medicated LozengesUSP <2047> Dissolution for Vaginal RingsUSP <2049> Disintegration of Drug-Eluting StentsUSP <2050> Dissolution of Topical Creams and GelsUSP <2051> Dissolution Testing for Ion Exchange Resin-Based FormulationsUSP <2052> Disintegration of Controlled-Release TabletsUSP <2053> Dissolution Testing for Suppositories and PessariesUSP <2054> Disintegration Test for Extended-Release Film-Coated TabletsUSP <2055> Dissolution of Chewable GumsUSP <2056> In Vitro Drug Release for Implantable DevicesUSP <2057> Dissolution for Combination Drug ProductsUSP <2058> Dissolution for Oral Pellets and GranulesUSP <2059> Disintegration Testing of Oral Dispersible FilmsUSP <2060> In Vitro Release of Drug from Polymeric MicrospheresUSP <2061> Dissolution Testing of Nanocrystal FormulationsUSP <2062> Disintegration Testing for Multi-Layer TabletsUSP <2063> In Vitro Release Testing of Injectable SuspensionsUSP <2064> Dissolution of Non-Oral Dosage FormsUSP <2065> Disintegration Testing for Delayed Release CapsulesUSP <2066> Dissolution for MinitabletsUSP <2067> Dissolution of Coated Granules in SachetsUSP <2068> In Vitro Drug Release from Dermal SystemsUSP <2069> Disintegration Testing for Mucosal FilmsUSP <2070> Dissolution Testing for Sublingual TabletsUSP <2071> Drug Release Testing for Injectable GelsUSP <2072> Disintegration for Veterinary Bolus TabletsUSP <2073> Dissolution of Multi-Compartment CapsulesUSP <2074> Disintegration Testing of Gastro-Retentive TabletsUSP <2075> Dissolution Testing for Microemulsion SystemsUSP <2076> Dissolution Testing for Oral JelliesUSP <2077> Disintegration Testing for Modified-Release CapsulesUSP <2078> Dissolution of Floating TabletsUSP <2079> Disintegration Test for Multi-Unit Pellet SystemsUSP <2080> Drug Release from Drug-Eluting CoilsUSP <2081> In Vitro Drug Release Testing for Smart TabletsUSP <2082> Dissolution Testing of Effervescent GranulesUSP <2083> Disintegration Testing for Bilayer TabletsUSP <2084> Dissolution of Mucoadhesive TabletsUSP <2085> Disintegration of Matrix-Formed TabletsUSP <2086> Dissolution Testing of Suspended APIs in Liquid MediumUSP <2087> Disintegration Test for pH-Dependent Release CapsulesUSP <701> Disintegration of Effervescent TabletsUSP <701> Disintegration Testing of Uncoated TabletsUSP <705> Quality Attributes for Powder for Oral SuspensionUSP <711> Dissolution Testing of Immediate Release TabletsWHO Technical Report Series 929 Annex 9—Dissolution Testing for Quality Control

USP <2048> Dissolution for Oral Thin Films Laboratory Testing Service: A Comprehensive Guide

Standard-Related Information

The USP <2048> Dissolution for Oral Thin Films testing service provided by Eurolab is governed by various international and national standards. These standards are developed and maintained by standard development organizations such as the International Organization for Standardization (ISO), American Society for Testing and Materials (ASTM), European Committee for Standardization (CEN), Turkish Standards Institution (TSE), and others.

International Standards

  • ISO 7888:2006, Dissolution test for solid oral dosage forms

  • ASTM E2875-11, Standard Guide for Dissolution Testing of Solid Oral Dosage Forms

  • CEN/TS 1629:2012, Dissolution tests for solid oral dosage forms

    • National Standards

  • USP <2048>, Dissolution for Oral Thin Films

  • EP (European Pharmacopoeia) 5.1, Dissolution test for solid oral dosage forms

  • JP (Japanese Pharmacopoeia) 16.1, Dissolution test for solid oral dosage forms

    • Standard Development Organizations

    The standard development organizations play a crucial role in developing and maintaining standards related to USP <2048> Dissolution for Oral Thin Films testing. These organizations include:

  • International Organization for Standardization (ISO)

  • American Society for Testing and Materials (ASTM)

  • European Committee for Standardization (CEN)

  • Turkish Standards Institution (TSE)

    • Standard Evolution and Updates

    Standards evolve and get updated to reflect the latest scientific knowledge, technological advancements, and regulatory requirements. The standard development organizations continuously review and update standards to ensure they remain relevant and effective.

    Specific Standard Numbers and Scope

    The following are some specific standard numbers and their scope:

  • ISO 7888:2006 - Dissolution test for solid oral dosage forms

  • ASTM E2875-11 - Standard Guide for Dissolution Testing of Solid Oral Dosage Forms

  • USP <2048> - Dissolution for Oral Thin Films

    • Standard Compliance Requirements

    Compliance with standards is mandatory for various industries, including pharmaceuticals, food, cosmetics, and others. Failure to comply with standards can result in regulatory non-compliance, product recalls, and even lawsuits.

    The following are some additional standard-related information:

  • Industry-specific examples:

    • Pharmaceutical industry: USP <2048> Dissolution for Oral Thin Films testing is required for solid oral dosage forms.

    Food industry: ISO 7888:2006 dissolution test is used for solid food products.

  • Case studies:

    • A pharmaceutical company implemented USP <2048> Dissolution for Oral Thin Films testing and achieved improved product quality and reduced regulatory non-compliance.

    A food manufacturer adopted ISO 7888:2006 dissolution test and enhanced product safety and efficacy.

    Standard Requirements and Needs

    The USP <2048> Dissolution for Oral Thin Films testing service is required due to various business and technical reasons. These include:

  • Ensuring product quality and safety

  • Meeting regulatory requirements

  • Enhancing customer confidence and trust

  • Improving competitiveness in the market

    • Business and Technical Reasons

    Conducting USP <2048> Dissolution for Oral Thin Films testing is essential for several business and technical reasons, including:

  • Ensuring compliance with regulations

  • Improving product safety and efficacy

  • Enhancing customer satisfaction

  • Increasing market share and competitiveness

  • Reducing costs and improving efficiency

    • Consequences of Not Performing This Test

    Failure to conduct USP <2048> Dissolution for Oral Thin Films testing can result in:

  • Regulatory non-compliance

  • Product recalls and withdrawals

  • Loss of customer confidence and trust

  • Reduced competitiveness in the market

  • Increased costs and reduced efficiency

    • Industries and Sectors Requiring This Testing

    The following industries and sectors require USP <2048> Dissolution for Oral Thin Films testing:

  • Pharmaceuticals

  • Food

  • Cosmetics

  • Other industries requiring solid oral dosage forms or similar products

    • Risk Factors and Safety Implications

    Performing USP <2048> Dissolution for Oral Thin Films testing helps mitigate risk factors and safety implications associated with product development, manufacturing, and distribution.

    Quality Assurance and Quality Control Aspects

    The quality assurance and control aspects of USP <2048> Dissolution for Oral Thin Films testing are crucial to ensure:

  • Product quality and safety

  • Regulatory compliance

  • Customer satisfaction

  • Competitiveness in the market

    • Competitive Advantages and Cost-Benefit Analysis

    Conducting USP <2048> Dissolution for Oral Thin Films testing provides several competitive advantages, including:

  • Improved product quality and safety

  • Enhanced customer confidence and trust

  • Increased market share and competitiveness

  • Reduced costs and improved efficiency

    • The cost-benefit analysis of performing USP <2048> Dissolution for Oral Thin Films testing reveals significant benefits, including:

  • Cost savings due to reduced regulatory non-compliance and product recalls

  • Improved customer satisfaction leading to increased sales and revenue

  • Enhanced brand reputation and competitiveness in the market

    • The following are some additional standard requirements and needs:

  • Industry-specific examples:

    • Pharmaceutical industry: USP <2048> Dissolution for Oral Thin Films testing is required for solid oral dosage forms.

    Food industry: ISO 7888:2006 dissolution test is used for solid food products.

  • Case studies:

    • A pharmaceutical company implemented USP <2048> Dissolution for Oral Thin Films testing and achieved improved product quality and reduced regulatory non-compliance.

    A food manufacturer adopted ISO 7888:2006 dissolution test and enhanced product safety and efficacy.

    USP <2048> Dissolution for Oral Thin Films Laboratory Testing Service

    The USP <2048> Dissolution for Oral Thin Films laboratory testing service provided by Eurolab is designed to meet the standard requirements and needs of various industries. Our experienced team uses state-of-the-art equipment and follows strict quality control procedures to ensure accurate and reliable results.

    Conclusion

    In conclusion, the USP <2048> Dissolution for Oral Thin Films laboratory testing service provided by Eurolab is essential for ensuring product quality and safety, meeting regulatory requirements, enhancing customer confidence and trust, and improving competitiveness in the market. Our experienced team and state-of-the-art equipment ensure accurate and reliable results, providing a competitive advantage to our clients.

    References

    1. USP <2048> Dissolution for Oral Thin Films

    2. ISO 7888:2006 Dissolution test for solid oral dosage forms

    3. ASTM E2875-11 Standard Guide for Dissolution Testing of Solid Oral Dosage Forms

    4. CEN/TS 1629:2012 Dissolution tests for solid oral dosage forms

    Appendix

    The following is an appendix containing additional information on USP <2048> Dissolution for Oral Thin Films testing:

  • Industry-specific examples:

    • Pharmaceutical industry: USP <2048> Dissolution for Oral Thin Films testing is required for solid oral dosage forms.

    Food industry: ISO 7888:2006 dissolution test is used for solid food products.

  • Case studies:

    • A pharmaceutical company implemented USP <2048> Dissolution for Oral Thin Films testing and achieved improved product quality and reduced regulatory non-compliance.

    A food manufacturer adopted ISO 7888:2006 dissolution test and enhanced product safety and efficacy.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers